| | | |  | Antoine COLBOCHead of Venture Capital activities |  | |  |  |  |  |  |  |
| |  | Philippe GUINOTSenior Partner |  | |  |  |  |  |  |  |
| |  | Philippe GUINOTSenior Partner | | | |
Dr Guinot joined Crédit Lyonnais Private Equity in July 2001 to create the firm's Biotechnology
and Life Sciences investments portfolio.
Dr Guinot is a Medical Doctor and an anesthetist. He also holds a PhD in Life
Sciences and is the author of numerous international scientific articles. From
1977 to 1994, he pursued his career in the pharmaceutical industry in business
and drug development, working for several international laboratories in Switzerland,
France, Germany and the UK.
During this time, he was in charge of the development of new drugs, several of
which are marketed today. He was also appointed Adjunct Professor of Medicine
at the University of California, Davis, from 1992 to 1996. Dr Guinot then managed
three US and French Biotechnology companies in France. He currently serves on
the boards of eight companies and on the finance advisory board of AFMTéléthon
(French Muscular Dystrophy Association). |  |  |  |  |  |  |
| |  | Michel de LEMPDESInvestment Director |  | |  |  |  |  |  |  |
| |  | Marc DEVILLARDInvestment Director |  | |  |  |  |  |  |  |
| |  | Marc DEVILLARDInvestment Director | | | |
Marc Devillard joins Crédit Agricole Private Equity's Venture Capital team in February 2008
as Investment Director for the software and Internet sectors.
He is a graduate of the Ecole Polytechnique and the Corps des Ponts et Chaussées
engineering school. He also has an MBA from the INSEAD business school.
Marc Devillard began his career as a field engineer in Papua New Guinea for Spie
Capag. In 1993, he joined McKinsey & Company as a consultant specialising in the
financial and industrial sectors before moving to Mitchell Madison Group as senior
project manager. In 1998, he was appointed Business Development Director at BIC
S.A. Then in 2000, he became chief operating officer of Cytale S.A., producer
of the first European e-book, the Cybook, and was appointed member of the management
board. In 2003, he joined Microsoft France as head of the "Information Worker"
product line. Two years later, he was appointed head of marketing operations and
then in 2006 head of planning and marketing operations for Western Europe. Since
2007, he has been Senior Manager in the Telecoms/Media division of management
consultancy Arthur D. Little.
|  |  |  |  |  |  |
 |
| |  | Bernard NABETInvestment Director |  | |  |  |  |  |  |  |
| |  | Bernard NABETInvestment Director | | | |
Bernard Nabet joined the Venture Capital department of Crédit Agricole Private Equity in September
2005, as an Investment Manager and will focus mainly on the IT sector. Since 2007,
he is based in Tel Aviv to develop the fund of fund activity in Israel.
He graduated from the Ecole Nationale Supérieure d'Electronique, Informatique
et Radiocommunications (French engineering school) in Bordeaux and holds a DEA
(post-graduate diploma) in Applied Physics and Microelectronics and a DESS (specialised
post-graduate diploma) in Business Administration from the IAE (institute of business
administration) Paris.
Bernard Nabet began his career as a Research Engineer at France Telecom R&D in
the optoelectronic laboratories, and later worked for several years in consulting
at Arthur Andersen and later at A.T. Kearney Interactive. He managed many projects
in the areas of consulting, design, architecture and deployment of business IT
systems.
In 2000, he co-founded Negopartner, a company specialised in "e-sourcing" solutions
for SMEs. As CEO, he was in particular responsible for strategic planning, development
and financial control.
He started working in the field of Private Equity in 2001 when he was hired as
a Partner in the Spef eFund structure of the Venture Capital department of the
Natexis group. |  |  |  |  |  |  |
 |
| |  | Alexia PEROUSEInvestment Director |  | |  |  |  |  |  |  |
| |  | Alexia PEROUSEInvestment Director | | | |
Alexia Perouse joined Crédit Agricole Private Equity in January 2005 as partner in the Life
Sciences sector.
She holds a MSc in Neurosciences from the University of Lyon and a MBA from the
Institute of Administration of Enterprises (Lyon).
Alexia Perouse started her career in 1996 as project leader for Chiron Vaccines
and then as project manager for Parteurop Développement. She was in charge of
the valorization of innovative projects and start-ups in the Biotechnology field.
In 1999, she joined the venture capital activity as associate in Sofinnova Partners
and has been actively involved in the decision-making on several investments.
She currently serves on the boards of four companies. |  |  |  |  |  |  |
| |  | Emmanuelle COUTANCEAUAssociate |  | |  |  |  |  |  |  |
| |  | Emmanuelle COUTANCEAUAssociate | | | |
Emmanuelle Coutanceau joined Crédit Agricole Private Equity's Venture Capital team in April 2007.
She holds a degree in agronomic engineering from the ENSAR in Rennes, a PhD in
Microbiology from Paris VII University and a specialized postgraduate degree in
pharmaceutical management from the Paris ESCP-EAP Business School.
From 2003 to 2006, at Pasteur Institute, Emmanuelle Coutanceau managed a fundamental
research project on the immunosuppressive properties of a bacterial toxin. Her
work led to several international scientific publications. |  |  |  |  |  |  |
| |  | François-Xavier DEDDEAssociate |  | |  |  |  |  |  |  |
| |  | François-Xavier DEDDEAssociate | | | |
François-Xavier Dedde joined Crédit Agricole Private Equity's venture capital team in September 2006.
He holds both a degree in IT engineering from the ESIEE in
Paris
and a Masters specialised in finance from the Lyon School of Management.
François-Xavier began his professional career in 2004 as an analyst with Crédit
Lyonnais Private Equity's venture capital team (now Crédit Agricole Private Equity).
He has also worked with Calyon
New York
(Crédit Agricole's corporate and investment banking arm) where his responsibilities
included analysis of major North American accounts.
|  |  |  |  |  |  |
Credit Agricole Private Equity
100 Boulevard du Montparnasse
75682 PARIS Cedex 14
Standard : +33 1 43 23 21 21 | |